
Kanraby D 30mg/20mg Capsule SR
Marketer
Fortune Life Sciences Private Limited
Salt Composition
Domperidone (30mg) + Rabeprazole (20mg)
Overview Kanraby D 30mg/20mg Capsule SR
Gastroesophageal reflux disease (GERD, or acid reflux) can be managed with Kanraby D 30mg/20mg Sustained-Release Capsules, a dual-action formulation. This medication alleviates acidity symptoms like heartburn, stomach upset, and irritation by neutralizing stomach acid and facilitating gas expulsion. Take Kanraby D as prescribed, on an empty stomach, adhering to your doctor's dosage and treatment duration. Your specific dosage depends on your condition and response. Premature discontinuation may lead to symptom recurrence and disease exacerbation. Inform your physician about all other medications you're using, as interactions are possible. Common, usually transient side effects include diarrhea, abdominal pain, dry mouth, headache, gas, and fatigue. Report any concerning side effects immediately. Drowsiness and dizziness are potential side effects; avoid driving or mentally demanding tasks until the drug's impact is known. Alcohol consumption should be avoided due to potential increased drowsiness. Lifestyle adjustments, such as consuming cold milk and avoiding caffeinated beverages, spicy foods, and chocolate, may enhance treatment outcomes. Prior to initiating treatment, disclose any kidney or liver conditions, as well as pregnancy, pregnancy plans, or breastfeeding to your doctor.
Uses of Kanraby D 30mg/20mg Capsule SR
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Kanraby D 30mg/20mg Capsule SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the capsule whole; avoid chewing, crushing, or breaking it. Consume Kanraby D 30mg/20mg sustained-release capsules on an empty stomach.
Common Side effects of Kanraby D 30mg/20mg Capsule SR:
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Nasal congestion (stuffy nose)
- Insomnia (difficulty in sleeping)
- Fundic gland polyps
- Nausea
- Constipation
- Flatulence
- Back pain
- Pharyngitis
How to use Kanraby D 30mg/20mg Capsule SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the capsule whole; avoid chewing, crushing, or breaking it. Administer Kanraby D 30mg/20mg sustained-release capsules on an empty stomach.
How Kanraby D 30mg/20mg Capsule SR works:
Kanraby D 30mg/20mg sustained-release capsules contain Domperidone and Rabeprazole. Domperidone, a gastrointestinal motility stimulant, enhances stomach and intestinal transit, facilitating efficient food passage. Rabeprazole, a proton pump inhibitor (PPI), decreases gastric acid production, thereby alleviating acid indigestion and heartburn symptoms.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Kanraby D 30mg/20mg SR capsules with alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The use of Kanraby D 30mg/20mg SR capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Kanraby D 30mg/20mg capsule is likely unsuitable for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Kanraby D 30mg/20mg sustained-release capsules might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving is prohibited if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Kanraby D 30mg/20mg sustained-release capsules cautiously. Dosage modification for Kanraby D 30mg/20mg sustained-release capsules might be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Kanraby D 30mg/20mg SR capsules. Dosage modification may be necessary; physician consultation is advised. Kanraby D 30mg/20mg SR capsules are contraindicated in patients exhibiting moderate to severe hepatic dysfunction.
What if you forget to take Kanraby D 30mg/20mg Capsule SR :
Should you forget to take a Kanraby D 30mg/20mg Capsule SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Kanraby D 30mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
